These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9523214)

  • 1. FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population.
    Syrrou M; Georgiou I; Grigoriadou M; Petersen MB; Kitsiou S; Pagoulatos G; Patsalis PC
    Genet Epidemiol; 1998; 15(1):103-9. PubMed ID: 9523214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.
    Patsalis PC; Sismani C; Hettinger JA; Boumba I; Georgiou I; Stylianidou G; Anastasiadou V; Koukoulli R; Pagoulatos G; Syrrou M
    Am J Med Genet; 1999 May; 84(3):184-90. PubMed ID: 10331587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males.
    Barros Santos C; Gonçalves Pimentel MM
    Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of fragile X syndrome in a sample from Spanish Basque country.
    Arrieta I; Criado B; Martinez B; Telez M; Nuñez T; Peñagarikano O; Ortega B; Lostao CM
    Ann Genet; 1999; 42(4):197-201. PubMed ID: 10674158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10 years' experience in fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach.
    Sofocleous C; Kitsiou S; Fryssira H; Kolialexi A; Kalaitzidaki M; Roma E; Tsangaris GT; Chistofidou C; Metaxotou C; Kanavakis E; Mavrou A
    In Vivo; 2008; 22(4):451-5. PubMed ID: 18712171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of FRAXE allele sizes in three populations.
    Zhong N; Ju W; Curley D; Wang D; Pietrofesa J; Wu G; Shen Y; Pang C; Poon P; Liu X; Gou S; Kajanoja E; Ryynänen M; Dobkin C; Brown WT
    Am J Med Genet; 1996 Aug; 64(2):415-9. PubMed ID: 8844095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of FRAXE-positive subjects with mental impairement in two unrelated Italian families.
    Russo S; Selicorni A; Bedeschi MF; Natacci F; Viziello P; Fortuna R; Pagani G; Dalprà L; Larizza L
    Am J Med Genet; 1998 Jan; 75(3):304-8. PubMed ID: 9475603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
    Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
    Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males.
    Santos CB; Costa Lima MA; Pimentel MM
    Hum Mutat; 2001 Aug; 18(2):157-62. PubMed ID: 11462240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for high-risk haplotypes and (CGG)n expansion in fragile X syndrome in the Hellenic population of Greece and Cyprus.
    Syrrou M; Patsalis PC; Georgiou I; Hadjimarcou MI; Constantinou-Deltas CD; Pagoulatos G
    Am J Med Genet; 1996 Jul; 64(1):234-8. PubMed ID: 8826482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRAXE mutation analysis in three Spanish families.
    Carbonell P; López I; Gabarrón J; Bernabé MJ; Lucas JM; Guitart M; Gabau E; Glover G
    Am J Med Genet; 1996 Aug; 64(2):434-40. PubMed ID: 8844099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple multiplex FRAXA, FRAXE, and FRAXF PCR assay convenient for wide screening programs.
    Strelnikov V; Nemtsova M; Chesnokova G; Kuleshov N; Zaletayev D
    Hum Mutat; 1999; 13(2):166-9. PubMed ID: 10094554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers.
    Murray A; Youings S; Dennis N; Latsky L; Linehan P; McKechnie N; Macpherson J; Pound M; Jacobs P
    Hum Mol Genet; 1996 Jun; 5(6):727-35. PubMed ID: 8776586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Fra X syndrome among institutionalized mentally retarded males in Poland.
    Mazurczak T; Bocian E; Milewski M; Obersztyn E; Stańczak H; Bal J; Szamotulska K; Karwacki MW
    Am J Med Genet; 1996 Jul; 64(1):184-6. PubMed ID: 8826472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the gene FMR2, associated with FRAXE mental retardation.
    Gecz J; Gedeon AK; Sutherland GR; Mulley JC
    Nat Genet; 1996 May; 13(1):105-8. PubMed ID: 8673085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA diagnosis of FRAXA and FRAXE in Chinese children with neurodevelopmental disorders and fragile X syndrome.
    Chan SY; Wong V
    Clin Genet; 1998 Mar; 53(3):179-83. PubMed ID: 9630071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate alleles at the FRAXA and FRAXE loci in Parkinson's disease.
    Costa A; Gao L; Carrillo F; Cáceres-Redondo MT; Carballo M; Díaz-Martín J; Gómez-Garre P; Sobrino F; Lucas M; López-Barneo J; Mir P; Pintado E
    Parkinsonism Relat Disord; 2011 May; 17(4):281-4. PubMed ID: 21257332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities.
    Holden JJ; Julien-Inalsingh C; Chalifoux M; Wing M; Scott E; Fidler K; Swift I; Maidment B; Knight SJ; Davies KE; White BN
    Am J Med Genet; 1996 Aug; 64(2):420-3. PubMed ID: 8844096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.